 故事线索 / 详情

诺和诺德与礼来争夺GLP-1口服药市场，备战Medicare医保覆盖

Novo Nordisk vs Eli Lilly Competition in Oral GLP-1 Market and Medicare Coverage Battle

NVO LLY 2 篇报告

叙事时间线

CNBC 快讯 6月8日 14:30

Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with M…

CNBC 快讯 6月8日 17:10

"I think the majority view is that Lilly is pulling away, kind of Secretariat-like," Jim Cramer said Monday.